Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib

Although the rapid onset of effect of glucocorticoids (GCs) allows rapid control of rheumatoid arthritis (RA) symptoms, their chronic use may be associated with several adverse events. The 2022 update of EUALR recommendations for the management of patients with RA suggests to reduce and discontinue...

Descripción completa

Detalles Bibliográficos
Autores principales: Spinelli, Francesca Romana, Garufi, Cristina, Mancuso, Silvia, Ceccarelli, Fulvia, Truglia, Simona, Conti, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511736/
https://www.ncbi.nlm.nih.gov/pubmed/37730835
http://dx.doi.org/10.1038/s41598-023-42371-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511736/
https://www.ncbi.nlm.nih.gov/pubmed/37730835
http://dx.doi.org/10.1038/s41598-023-42371-z

Ejemplares similares